Shingles Market: Key Players, Therapies, and Epidemiology Segmentation by DelveInsight

iCrowdNewswire

Sep 08, 2021

 

shingles market

 

The Shingles market report provides current treatment practices, emerging drugs, Shingle’s market share of the individual therapies, current and forecasted Shingles market Size from 2017 to 2030 segmented by seven major markets. Unlike herpes simplex virus infections, which can recur many times, there is usually only one outbreak of shingles in a person’s lifetime. Fewer than 4% of people have more than one outbreak.

The Report also covers current Shingles treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.

Some of the key highlights of the Shingles Market Report Insights

  • An estimated one million cases of herpes occur annually in the United States.
  • Females are more commonly affected by Shingles than males.
  • The Major players of the Shingles Market like Novartis, GlaxoSmithKline, Maruho, and many others are involved in the report.
  • The Shingles Marketed Therapies such as Famvir (famciclovir), Valtrex (Valacyclovir), Amenalief (amenamevir), Shingrix, and many others are involved in the report.

 

Request for sample for deep insights into Shingles Market Report

Shingles Overview

Shingles, also known as herpes zoster (HZ), is a viral infection caused by the chickenpox virus, varicella-zoster virus (VZV). Herpes zoster results from activation of the virus, which in many instances has remained latent for years following a primary chickenpox infection. Once active, the virus travels along a nerve to the skin and causes a rash.

Shingles Epidemiology Segmentation in the 7MM for the Study period 2017-2030.

  • Total Shingles  Incident Cases.
  • Gender-specific Shingles Incident Cases.
  • Age-specific Shingles Incident Cases.
  • Shingles Diagnosed and Treatable Cases.

 

Visit for information- Shingles Market Insights

Shingles Epidemiology

Shingles rates have been increasing in the United States over a long period of time and the reasons for this are unclear. This trend continues among younger and middle aged adults, however since 2008 the rates among older adults have been plateauing.

Shingles Market

Shingrix is a new shingles vaccine developed by GlaxoSmithKline and was approved by the US FDA in 2017. It contains inactivated varicella-zoster viral particles, which aids the body’s production of more antibodies that are necessary to fight the virus with a stronger immune system response. 

Shingles Marketed Therapies

  • Famvir (famciclovir)
  • Valtrex (Valacyclovir)
  • Amenalief (amenamevir)
  • Shingrix
  • And many others

 

Shingles Market Companies

  • Novartis, 
  • GlaxoSmithKline, 
  • Maruho, 
  • and many others.

 

Shingles Market Report Key Strengths

  • 10 Years Forecast
  • 7MM Coverage
  • Tendinopathy Epidemiology Segmentation
  • Key Cross Competition
  • Highly Analyzed Market
  • Drugs Uptake

 

Key Questions Answered in the Shingles Market Report

  • What was the Shingles market share (%) distribution in 2017 and how it would look like in 2030?
  • What would be the Shingles total market size as well as market size by therapies across the 7MM during the forecast period (2017-2030)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Shingles market size during the forecast period (2017-2030)?
  • At what CAGR, is the Shingles market expected to grow in the 7MM during the forecast period (2017-2030)?
  • What would be the Shingles market outlook across the 7MM during the forecast period (2017-2030)?
  • What would be the Shingles market growth till 2030, and what will be the resultant market Size in the year 2030?
  • How would the market drivers, barriers, and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

 

You may speak to our experts- Shingles Market Report

Read Detailed Table of Content

  1. Key Insights
  2. Executive Summary of Shingles
  3. Competitive Intelligence Analysis for Shingles
  4. Shingles: Market Overview at a Glance
  5. Shingles: Disease Background and Overview
  6. Patient Journey
  7. Shingles Epidemiology and Patient Population
  8. Treatment Algorithm, Current Treatment, and Medical Practices
  9. Unmet Needs
  10. Key Endpoints of Shingles Treatment
  11. Marketed Products
  12. Emerging Therapies
  13. Shingles: Seven Major Market Analysis
  14. Attribute analysis
  15. 7MM: Market Outlook
  16. Access and Reimbursement Overview of Shingles
  17. KOL Views
  18. Market Drivers
  19. Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer
  23. About DelveInsight

Know More about the report- Shingles Market Outlook

Related Reports

Herpes Zoster Market

DelveInsight’s Herpes Zoster Market Insights, Epidemiology and Market Forecast – 2030 report provides a detailed overview of the disease and a depth understanding of historical and forecasted epidemiology.

Human Papillomavirus Market

DelveInsight’s s Human Papillomavirus (HPV) – Market Insights, Epidemiology and Market Forecast – 2030 report provides a detailed overview of the disease and in-depth understanding.

Pneumonia Market

DelveInsight’s Pneumonia, Pneumococcal – Market Insights, Epidemiology and Market Forecast – 2030 report provides a detailed overview of the disease and a depth understanding of historical and forecasted epidemiology.

Meningitis Market

DelveInsight’s s Meningitis – Market Insights, Epidemiology, and Market Forecast – 2030 report provides a detailed overview of the disease and a depth understanding of historical and forecasted epidemiology.

Hepatitis B Virus Market

DelveInsight’s s Hepatitis B Virus (HBV) Infection – Market Insights, Epidemiology, and Market Forecast – 2030 report provides a detailed overview of the disease and a depth understanding of historical and forecasted epidemiology.

Visit our blog section

  • Chronic Hepatitis B Treatment Market – DelveInsight
  • Evolution in Hepatitis B and C Virus: Can – DelveInsight
  • Global Hepatitis B Market Size – DelveInsight

 

About DelveInsight 

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences providing comprehensive end-to-end solutions to improve performance.  

Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve

For more insights into the Pharma industry, Visit Pharma, Healthcare, and Biotech Blog

Contact Information:

Shruti Thakur
info@delveinsight.com
+91-9650213330

YOU MAY ALSO LIKE

Vancouver’s Star power grows for year three…

    The Shingles market report provides current treatment practices, emerging drugs, Shingle’s market share of the individual therapies, current and forecasted Shingles market Size…

read more

Michelin Introduces MICHELIN BETTER HAUL ROAD: Developed…

    The Shingles market report provides current treatment practices, emerging drugs, Shingle’s market share of the individual therapies, current and forecasted Shingles market Size…

read more

Michelin Debuts Mining Industry’s First Energy-Efficient Tire,…

    The Shingles market report provides current treatment practices, emerging drugs, Shingle’s market share of the individual therapies, current and forecasted Shingles market Size…

read more